<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03329222</url>
  </required_header>
  <id_info>
    <org_study_id>EBB16SI06749</org_study_id>
    <nct_id>NCT03329222</nct_id>
  </id_info>
  <brief_title>An Infant Formula Trial on Dietary Management of Infantile Colic</brief_title>
  <official_title>A Randomised, Double Blind, Controlled, Multi-centre Study to Assess the Efficacy of an Infant Formula in the Dietary Management of Infantile Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Asia Pacific Holdings Pte, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Phramongkutklao College of Medicine and Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maharaj Nakorn Chiang Mai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Danone Asia Pacific Holdings Pte, Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised, double blind, controlled, multi-centre study to assess the efficacy of an
      infant formula in the dietary management of infantile colic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomised, double blind, controlled, multi-centre study to assess the efficacy of an
      infant formula in the dietary management of infantile colic.

      The hypothesis of the study is that the test product, compared to the control formula, will
      reduce the crying time in infants with infantile colic.

      The various time points of the outcome are:

      V1 (screening : Day -5 to day 0); V2 ( Randomization: Day 0); V3 (Day 7); V4 (Day 21); Phone
      Call (Day 28); V5 (End -intervention: Day 42); V6 (Day 56)
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    slow recruitment
  </why_stopped>
  <start_date type="Actual">October 27, 2017</start_date>
  <completion_date type="Actual">July 3, 2018</completion_date>
  <primary_completion_date type="Actual">July 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, two arms</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Daily inconsolable crying time using data recorded on subject's diaries</measure>
    <time_frame>6 weeks</time_frame>
    <description>Daily inconsolable crying time over 6 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily crying time using data recorded on subject's diaries</measure>
    <time_frame>6 weeks</time_frame>
    <description>Daily crying time over 6 weeks of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily fussing time using data recorded on subject's diaries</measure>
    <time_frame>6 weeks</time_frame>
    <description>Daily fussing time over 6 weeks of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily inconsolable fussing time using data recorded on subject's diaries</measure>
    <time_frame>6 weeks</time_frame>
    <description>Daily inconsolable fussing time over 6 weeks of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily stool frequency using data recorded on subject's diaries</measure>
    <time_frame>6 weeks</time_frame>
    <description>Daily stool frequency over 6 weeks of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily stool consistency using data recorded on subject's diaries</measure>
    <time_frame>6 weeks</time_frame>
    <description>Daily stool consistency over 6 weeks of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The frequency of subject's GI symptoms of digestion in the 7-day period prior to the visit using the Infant gastrointestinal symptoms questionnaire</measure>
    <time_frame>6 weeks</time_frame>
    <description>Gastrointestinal symptoms using the Infant gastrointestinal symptoms questionnaire during the 6-week intervention period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The intensity of subject's GI symptoms of digestion in the 7-day period prior to the visit using the Infant gastrointestinal symptoms questionnaire</measure>
    <time_frame>6 weeks</time_frame>
    <description>Gastrointestinal symptoms using the Infant gastrointestinal symptoms questionnaire during the 6-week intervention period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Infantile Colic</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An infant formula which contains specific hydrolysed proteins with a fat blend, prebiotics mixture, starch and reduced lactose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard cow's milk with prebiotics mixture</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific hydrolysed proteins</intervention_name>
    <description>An infant formula which contains specific hydrolysed proteins with a fat blend, prebiotics mixture, starch and reduced lactose</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard cow's milk with prebiotics mixture</intervention_name>
    <description>Standard cow's milk with prebiotics mixture</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Infants aged 21-56 days (both inclusive);

          2. Gestation age 37-42 weeks;

          3. Normal birth weight for gestational age and gender

          4. 5-minute APGAR score &gt;7;

          5. Diagnosed with infantile colic ;

          6. Fully formula fed for at least 7 days before randomisation;

          7. Written informed consent from the parent and/or legal representative.

        Exclusion Criteria:

          1. Any plausible cause of inconsolable crying as judged by the investigator;

          2. Presence of non-functional vomiting or failure to thrive;

          3. Presence of any congenital defects in the gastrointestinal system or other defects
             preventing oral nutrition;

          4. Congenital condition and/or previous or current illness/infection and (or) medication
             use that could interfere with the main study outcomes;

          5. Known cow's milk protein allergy, lactose intolerance, or galactosaemia; including
             presence of any allergic manifestations;

          6. Received any special formula (e.g. lactose-free, hydrolysed protein);

          7. Received any of the following products/medication within 7 days before randomisation:

               1. Probiotics

               2. Systemic antibiotics

               3. Prokinetics

               4. Proton pump inhibitors

          8. Twins or triplets or other infant(s) &lt;6 months of age living in the same household;

          9. Incapability of the parent(s) to comply with the study protocol or investigator's
             uncertainty about the willingness or ability of the subject to comply with the
             protocol requirements;

         10. Current participation in another clinical study involving investigational or marketed
             products.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>56 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National University Hospital, Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phramongkutklao Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>October 3, 2017</study_first_submitted>
  <study_first_submitted_qc>October 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2017</study_first_posted>
  <last_update_submitted>September 7, 2018</last_update_submitted>
  <last_update_submitted_qc>September 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

